WEEK 38 – N°1 of “MyList” with * * * stocks: DXCM

  • Loading stock data...

DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients.

* * * stock
Average yearly return: +38%
Fair value: $435
Discount: 12%

Dexcom projects 37.8% earnings growth for the next five years. Over the past year, the company’s share price has risen 152.2% compared with the industry’s 16.1% growth.

Strong buy
Strong sell
Only a feeling

If you found this site useful and want to help keep it alive, 

Buy Me A Coffee
We Love Coffee

 to cover the costs and keep the site free of advertisements! Thank you for your support!

Over BillBull

Investment strategist. Never ask me why: 'T.A.' only

Geef een antwoord

Het e-mailadres wordt niet gepubliceerd. Vereiste velden zijn gemarkeerd met *

Deze website gebruikt Akismet om spam te verminderen. Bekijk hoe je reactie-gegevens worden verwerkt.